Clinical Trial Update: EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer [NA]

View source ↗

Summary

This trial evaluated EF5 as a hypoxia marker to detect oxygen levels and vasculature in tumor cells during photodynamic therapy for intraperitoneal or pleural c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Ascites
• Malignant Mesothelioma
• Peritoneal Cancer

Drugs mentioned

• EF5

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Malignant Mesothelioma, Localized Malignant Mesothelioma | NA | Status: TERMINATED